Moderna, Inc. (MRNA) Operating cash flow 2016–2025
Moderna, Inc. (MRNA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$1.9BFY2025 · since FY2016: $66.7M → -$1.9B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$1.9B | +37.6% |
| FY2024 | -$3.0B | +3.7% |
| FY2023 | -$3.1B | -162.6% |
| FY2022 | $5.0B | -63.4% |
| FY2021 | $13.6B | +571.9% |
| FY2020 | $2.0B | +541.6% |
| FY2019 | -$459.0M | -38.7% |
| FY2018 | -$330.9M | +0.2% |
| FY2017 | -$331.5M | -596.7% |
| FY2016 | $66.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More MRNA financial trends
MRNA RevenueMRNA Net incomeMRNA Net marginMRNA Gross profitMRNA Gross marginMRNA Operating incomeMRNA Operating marginMRNA Free cash flowMRNA Capital expendituresMRNA Return on equityMRNA Stock buybacksMRNA Dividends paidMRNA Total assetsMRNA Total liabilitiesMRNA Shareholders’ equityMRNA overview →